CD4 and lung adenocarcinoma: Furthermore, an elevated presence of tumor-infiltrating CD4+ FOXP3+ Tregs has been described in patients with the 'mesenchymal' lung adenocarcinoma phenotype in comparison to those with an 'epithelial' lung adenocarcinoma phenotype [321].